Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Usability Testing of an Interactive Dashboard for Surgical Quality Improvement in a Large Congenital Heart Center.

Wu DTY, Vennemeyer S, Brown K, Revalee J, Murdock P, Salomone S, France A, Clarke-Myers K, Hanke SP.

Appl Clin Inform. 2019 Oct;10(5):859-869. doi: 10.1055/s-0039-1698466. Epub 2019 Nov 13.

PMID:
31724143
2.

The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.

Leggio GM, Torrisi SA, Mastrogiacomo R, Mauro D, Chisari M, Devroye C, Scheggia D, Nigro M, Geraci F, Pintori N, Giurdanella G, Costa L, Bucolo C, Ferretti V, Sortino MA, Ciranna L, De Luca MA, Mereu M, Managò F, Salomone S, Drago F, Papaleo F.

Mol Psychiatry. 2019 Sep 6. doi: 10.1038/s41380-019-0511-4. [Epub ahead of print]

PMID:
31492942
3.

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway.

Lazzara F, Fidilio A, Platania CBM, Giurdanella G, Salomone S, Leggio GM, Tarallo V, Cicatiello V, De Falco S, Eandi CM, Drago F, Bucolo C.

Biochem Pharmacol. 2019 Oct;168:341-351. doi: 10.1016/j.bcp.2019.07.021. Epub 2019 Jul 25.

PMID:
31351870
4.

Minimally invasive non-surgical vs. surgical approach for periodontal intrabony defects: a randomised controlled trial.

Nibali L, Koidou V, Salomone S, Hamborg T, Allaker R, Ezra R, Zou L, Tsakos G, Gkranias N, Donos N.

Trials. 2019 Jul 27;20(1):461. doi: 10.1186/s13063-019-3544-8.

5.

Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor.

Platania CBM, Lazzara F, Fidilio A, Fresta CG, Conti F, Giurdanella G, Leggio GM, Salomone S, Drago F, Bucolo C.

Biochem Pharmacol. 2019 Oct;168:249-258. doi: 10.1016/j.bcp.2019.07.010. Epub 2019 Jul 11.

PMID:
31302133
6.

Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas.

Bucolo C, Leggio GM, Drago F, Salomone S.

Pharmacol Ther. 2019 Nov;203:107392. doi: 10.1016/j.pharmthera.2019.07.003. Epub 2019 Jul 9. Review.

PMID:
31299315
7.

Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1.

Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso G, Fidilio A, Musso N, Sanfilippo G, Tascedda F, Palmeri A, Salomone S, Drago F, Puzzo D, Leggio GM, Caraci F.

Front Pharmacol. 2019 Jun 21;10:693. doi: 10.3389/fphar.2019.00693. eCollection 2019.

8.

Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS.

Morello G, Guarnaccia M, Spampinato AG, Salomone S, D'Agata V, Conforti FL, Aronica E, Cavallaro S.

Sci Rep. 2019 Jul 10;9(1):9968. doi: 10.1038/s41598-019-46355-w.

9.

Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System.

Torrisi SA, Leggio GM, Drago F, Salomone S.

Front Pharmacol. 2019 Apr 17;10:404. doi: 10.3389/fphar.2019.00404. eCollection 2019. Review.

10.

Forehead Tremor: A Clinical Presentation of Myasthenia Gravis?

Sciacca G, Reggio E, Donzuso G, Nicoletti A, Drago F, Salomone S, Zappia M.

Mov Disord Clin Pract. 2018 Feb 18;5(2):225-226. doi: 10.1002/mdc3.12593. eCollection 2018 Mar-Apr. No abstract available. Erratum in: Mov Disord Clin Pract. 2019 Apr 29;6(5):420.

11.

Dopaminergic-GABAergic interplay and alcohol binge drinking.

Leggio GM, Di Marco R, Gulisano W, D'Ascenzo M, Torrisi SA, Geraci F, Lavanco G, Dahl K, Giurdanella G, Castorina A, Aitta-Aho T, Aceto G, Bucolo C, Puzzo D, Grassi C, Korpi ER, Drago F, Salomone S.

Pharmacol Res. 2019 Mar;141:384-391. doi: 10.1016/j.phrs.2019.01.022. Epub 2019 Jan 12.

PMID:
30648615
12.

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.

Stark T, Ruda-Kucerova J, Iannotti FA, D'Addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V.

Neuropharmacology. 2019 Mar 1;146:212-221. doi: 10.1016/j.neuropharm.2018.11.035. Epub 2018 Nov 26.

PMID:
30496751
13.

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

Falzone L, Salomone S, Libra M.

Front Pharmacol. 2018 Nov 13;9:1300. doi: 10.3389/fphar.2018.01300. eCollection 2018. Review.

14.

Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis.

Giurdanella G, Montalbano G, Gennuso F, Brancati S, Lo Furno D, Augello A, Bucolo C, Drago F, Salomone S.

J Cell Physiol. 2019 Mar;234(3):1978-1986. doi: 10.1002/jcp.27545. Epub 2018 Oct 14.

PMID:
30317595
15.

Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy.

Platania CBM, Leggio GM, Drago F, Salomone S, Bucolo C.

Biochem Pharmacol. 2018 Dec;158:13-26. doi: 10.1016/j.bcp.2018.09.016. Epub 2018 Sep 15.

PMID:
30222965
16.

Retinal Protection and Distribution of Curcumin in Vitro and in Vivo.

Platania CBM, Fidilio A, Lazzara F, Piazza C, Geraci F, Giurdanella G, Leggio GM, Salomone S, Drago F, Bucolo C.

Front Pharmacol. 2018 Jun 22;9:670. doi: 10.3389/fphar.2018.00670. eCollection 2018.

17.

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.

Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V, Salvo V, Falsaperla R, Vitaliti G, La Rosa M, Leonardi S, Rotondo A, Avola N, Sgarlata D, Damiano A, Tirantello M, Anzelmo G, Cipolla D, Rizzo A, Russo A, Ruggieri M, Salomone S, Drago F.

Curr Drug Saf. 2018;13(3):200-207. doi: 10.2174/1574886313666180619120406.

PMID:
29921210
18.

Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome.

Sciacca G, Nicoletti A, Mostile G, Luca A, Raciti L, Dibilio V, Drago F, Salomone S, Zappia M.

Eur J Neurol. 2018 Aug;25(8):1100-e85. doi: 10.1111/ene.13673. Epub 2018 Jun 12.

PMID:
29754397
19.

Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice.

Hiroi Y, Noma K, Kim HH, Sladojevic N, Tabit CE, Li Y, Soydan G, Salomone S, Moskowitz MA, Liao JK.

Circ J. 2018 Mar 23;82(4):1195-1204. doi: 10.1253/circj.CJ-17-0732. Epub 2018 Jan 19.

20.

Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis.

Sciacca G, Reggio E, Mostile G, Nicoletti A, Drago F, Salomone S, Zappia M.

Neurol Sci. 2018 Feb;39(2):341-345. doi: 10.1007/s10072-017-3194-0. Epub 2018 Jan 12.

PMID:
29330628
21.

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.

Torrisi SA, Salomone S, Geraci F, Caraci F, Bucolo C, Drago F, Leggio GM.

Front Pharmacol. 2017 Oct 4;8:710. doi: 10.3389/fphar.2017.00710. eCollection 2017.

22.

Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases.

Platania CBM, Fisichella V, Fidilio A, Geraci F, Lazzara F, Leggio GM, Salomone S, Drago F, Pignatello R, Caraci F, Bucolo C.

Int J Mol Sci. 2017 Sep 30;18(10). pii: E2076. doi: 10.3390/ijms18102076.

23.

Erratum to: Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial.

Goodwin A, Salomone S, Bolton P, Charman T, Jones EJH, Mason L, Pickles A, Robinson E, Smith T, Sonuga-Barke EJS, Wass S, Johnson MH.

Trials. 2017 Sep 11;18(1):419. doi: 10.1186/s13063-017-2167-1. No abstract available.

24.

Safety of Antiplatelet Agents: Analysis of 'Real-World' Data from the Italian National Pharmacovigilance Network.

Gozzo L, Navarria A, Benfatto G, Longo L, Mansueto S, Sottosanti L, Pani L, Salomone S, Drago F.

Clin Drug Investig. 2017 Nov;37(11):1067-1081. doi: 10.1007/s40261-017-0566-4.

25.

Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Villari A, Giurdanella G, Bucolo C, Drago F, Salomone S.

Front Pharmacol. 2017 Jul 18;8:480. doi: 10.3389/fphar.2017.00480. eCollection 2017.

26.

Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE.

Giurdanella G, Lazzara F, Caporarello N, Lupo G, Anfuso CD, Eandi CM, Leggio GM, Drago F, Bucolo C, Salomone S.

Biochem Pharmacol. 2017 Oct 15;142:145-154. doi: 10.1016/j.bcp.2017.06.130. Epub 2017 Jun 23.

PMID:
28651842
27.

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.

Sortino MA, Salomone S, Carruba MO, Drago F.

Front Pharmacol. 2017 Jun 8;8:341. doi: 10.3389/fphar.2017.00341. eCollection 2017. Review.

28.

P2X7 receptor antagonism: Implications in diabetic retinopathy.

Platania CBM, Giurdanella G, Di Paola L, Leggio GM, Drago F, Salomone S, Bucolo C.

Biochem Pharmacol. 2017 Aug 15;138:130-139. doi: 10.1016/j.bcp.2017.05.001. Epub 2017 May 4.

PMID:
28479300
29.

Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study.

Romano GL, Platania CBM, Drago F, Salomone S, Ragusa M, Barbagallo C, Di Pietro C, Purrello M, Reibaldi M, Avitabile T, Longo A, Bucolo C.

Front Pharmacol. 2017 Mar 30;8:168. doi: 10.3389/fphar.2017.00168. eCollection 2017.

30.

New drugs in psychiatry: focus on new pharmacological targets.

Caraci F, Leggio GM, Salomone S, Drago F.

F1000Res. 2017 Mar 30;6:397. doi: 10.12688/f1000research.10233.1. eCollection 2017. Review.

31.

Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial.

Goodwin A, Salomone S, Bolton P, Charman T, Jones EJH, Mason L, Pickles A, Robinson E, Smith T, Sonuga-Barke EJS, Wass S, Johnson MH.

Trials. 2016 Dec 28;17(1):608. doi: 10.1186/s13063-016-1727-0. Erratum in: Trials. 2017 Sep 11;18(1):419. Mason, Luke [added].

32.

Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.

Castellano S, Ventimiglia A, Salomone S, Ventimiglia A, De Vivo S, Signorelli MS, Bellelli E, Santagati M, Cantarella RA, Fazio E, Aguglia E, Drago F, Di Nuovo S, Caraci F.

CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298.

PMID:
27712575
33.

Current drug treatments targeting dopamine D3 receptor.

Leggio GM, Bucolo C, Platania CB, Salomone S, Drago F.

Pharmacol Ther. 2016 Sep;165:164-77. doi: 10.1016/j.pharmthera.2016.06.007. Epub 2016 Jun 22. Review.

PMID:
27343365
34.

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression.

Maugeri G, D'Amico AG, Reitano R, Magro G, Cavallaro S, Salomone S, D'Agata V.

Front Pharmacol. 2016 May 31;7:139. doi: 10.3389/fphar.2016.00139. eCollection 2016.

35.

Linking the Price of Cancer Drug Treatments to Their Clinical Value.

Gozzo L, Navarria A, Drago V, Longo L, Mansueto S, Pignataro G, Cicchetti A, Salomone S, Drago F.

Clin Drug Investig. 2016 Jul;36(7):579-89. doi: 10.1007/s40261-016-0403-1.

PMID:
27153824
36.

The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.

Leggio GM, Catania MV, Puzzo D, Spatuzza M, Pellitteri R, Gulisano W, Torrisi SA, Giurdanella G, Piazza C, Impellizzeri AR, Gozzo L, Navarria A, Bucolo C, Nicoletti F, Palmeri A, Salomone S, Copani A, Caraci F, Drago F.

Pharmacol Res. 2016 Apr;106:10-20. doi: 10.1016/j.phrs.2016.02.007. Epub 2016 Feb 10.

PMID:
26875816
37.

TGF-β1 prevents rat retinal insult induced by amyloid-β (1-42) oligomers.

Fisichella V, Giurdanella G, Platania CB, Romano GL, Leggio GM, Salomone S, Drago F, Caraci F, Bucolo C.

Eur J Pharmacol. 2016 Sep 15;787:72-7. doi: 10.1016/j.ejphar.2016.02.002. Epub 2016 Feb 2.

PMID:
26845696
38.

Neuropsychological Deficits in Adult ADHD: Evidence for Differential Attentional Impairments, Deficient Executive Functions, and High Self-Reported Functional Impairments.

Salomone S, Fleming GR, Bramham J, O'Connell RG, Robertson IH.

J Atten Disord. 2016 Jan 14. pii: 1087054715623045. [Epub ahead of print]

PMID:
26769747
39.

Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution.

Marzagalli R, Leggio GM, Bucolo C, Pricoco E, Keay KA, Cardile V, Castorina S, Salomone S, Drago F, Castorina A.

Neuroscience. 2016 Mar 1;316:279-95. doi: 10.1016/j.neuroscience.2015.12.034. Epub 2015 Dec 21.

PMID:
26718601
40.

Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate.

Bucolo C, Musumeci M, Salomone S, Romano GL, Leggio GM, Gagliano C, Reibaldi M, Avitabile T, Uva MG, Musumeci S, Drago F.

Front Pharmacol. 2015 Nov 18;6:280. doi: 10.3389/fphar.2015.00280. eCollection 2015.

41.

Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach.

Platania CB, Di Paola L, Leggio GM, Romano GL, Drago F, Salomone S, Bucolo C.

Front Pharmacol. 2015 Oct 29;6:248. doi: 10.3389/fphar.2015.00248. eCollection 2015. Erratum in: Front Pharmacol. 2016;7:165.

42.

MicroRNA target prediction in glaucoma.

Romano GL, Platania CB, Forte S, Salomone S, Drago F, Bucolo C.

Prog Brain Res. 2015;220:217-40. doi: 10.1016/bs.pbr.2015.04.013. Epub 2015 Jun 30. Review.

PMID:
26497793
43.

Controversies in Glaucoma: Current Medical Treatment and Drug Development.

Bucolo C, Platania CB, Reibaldi M, Bonfiglio V, Longo A, Salomone S, Drago F.

Curr Pharm Des. 2015;21(32):4673-81. Review.

PMID:
26350532
44.

Folate status in type 2 diabetic patients with and without retinopathy.

Malaguarnera G, Gagliano C, Salomone S, Giordano M, Bucolo C, Pappalardo A, Drago F, Caraci F, Avitabile T, Motta M.

Clin Ophthalmol. 2015 Aug 7;9:1437-42. doi: 10.2147/OPTH.S77538. eCollection 2015.

45.

Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway.

Giurdanella G, Anfuso CD, Olivieri M, Lupo G, Caporarello N, Eandi CM, Drago F, Bucolo C, Salomone S.

Biochem Pharmacol. 2015 Aug 1;96(3):278-87. doi: 10.1016/j.bcp.2015.05.017. Epub 2015 Jun 6.

PMID:
26056075
46.

The effects of a Self-Alert Training (SAT) program in adults with ADHD.

Salomone S, Fleming GR, Shanahan JM, Castorina M, Bramham J, O'Connell RG, Robertson IH.

Front Hum Neurosci. 2015 Feb 10;9:45. doi: 10.3389/fnhum.2015.00045. eCollection 2015.

47.

Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation.

Pittalà V, Salerno L, Romeo G, Siracusa MA, Modica MN, Romano GL, Salomone S, Drago F, Bucolo C.

Eur J Pharmacol. 2015 Apr 5;752:78-83. doi: 10.1016/j.ejphar.2015.02.012. Epub 2015 Feb 19.

PMID:
25704612
48.

Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy.

Godfraind T, Salomone S.

Front Pharmacol. 2015 Feb 3;6:10. doi: 10.3389/fphar.2015.00010. eCollection 2015. No abstract available.

49.

Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.

Leggio GM, Torrisi SA, Castorina A, Platania CB, Impellizzeri AA, Fidilio A, Caraci F, Bucolo C, Drago F, Salomone S.

Eur Neuropsychopharmacol. 2015 Sep;25(9):1427-36. doi: 10.1016/j.euroneuro.2014.11.004. Epub 2014 Nov 15.

PMID:
25482686
50.

Regulation of vascular tone in rabbit ophthalmic artery: cross talk of endogenous and exogenous gas mediators.

Salomone S, Foresti R, Villari A, Giurdanella G, Drago F, Bucolo C.

Biochem Pharmacol. 2014 Dec 15;92(4):661-8. doi: 10.1016/j.bcp.2014.10.011. Epub 2014 Oct 29.

PMID:
25451691

Supplemental Content

Loading ...
Support Center